With conflict in the Middle East bringing on a global energy market squeeze, one major pharma supplier is raising prices ...
Wilmington PharmaTech, a CRDMO specializing in complex, custom active pharmaceutical ingredients (APIs) for small molecules, ...
The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.
EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) ...
Amazon Filters is a leading manufacturer of bespoke filter housings and high-performance filter media used in the manufacture of Active Pharmaceutical Ingredients (API's) - vital building blocks for ...
India Education Diary on MSN
HRV Pharma and Shodhana Laboratories forge unique strategic CDMO alliance to fast-track high-science & next-generation API development
India, March 31 -- HRV Global Life Sciences (HRV Pharma), India's first integrated Virtual API and Pharmtech company, today announced a comprehensive, multi-year Contract Development & Manufacturing ...
Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...
HAMBURG, GERMANY / ACCESSWIRE / November 5, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) has announced the sale of its chemical API manufacturing site, ...
“In the oil and gas industry, we drill as deep as the aerospace industry goes high,” says Arash Shadravan, Ph.D., global VP of the Energy Business Unit for polymer additive manufacturing (AM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results